References
- Linden O. Remission of a refractory, anaplastic large-cell lymphoma after treatment with daclizumab. New England Journal of Medicine 2004; 351: 1466–1467
- Koller C A, Kantarjian H M, Thomas D, O'Brien S, Rios M B, Kornblau S, et al. The hyper-CVAD regimen improves outcome in relapsed acute lymphoblastic leukemia. Leukemia 1997; 11: 2039–2044
- Seidemann K, Tiemann M, Schrappe M, Yakisan E, Simonitsch I, Janka-Schaub G, et al. Short-pulse B-non Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM90. Blood 2001; 97: 3699–3706
- Janik J E, Morris J C, Pittaluga S, McDonald K, Raffeld M, Jaffe E S, et al. Elevated serum-soluble interleukin-2 receptor levels in patients with anaplastic large cell lymphoma. Blood 2004; 104: 3355–3357